Evaluation of two short standardised regimens for the treatment of rifampicin-resistant tuberculosis (STREAM stage 2): an open-label, multicentre, randomised, non-inferiority trial. (2022)

First Author: Goodall RL
Attributed to:  Paediatric and adolescent infections funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/s0140-6736(22)02078-5

PubMed Identifier: 36368336

Publication URI: http://europepmc.org/abstract/MED/36368336

Type: Journal Article/Review

Volume: 400

Parent Publication: Lancet (London, England)

Issue: 10366

ISSN: 0140-6736